FindTrial
Sign In

Pain Associated With Endometriosis

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00758953
Enrollment
66
Registered
2008-09-25
Start date
2007-02-28
Completion date
2009-01-31
Last updated
2012-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometriosis

Brief summary

This study will evaluate the efficacy and safety of an investigational medication compared with placebo in the treatment of pain associated with endometriosis.

Interventions

DRUGDanazol Once Weekly

semi-solid

DRUGDanazol Twice Weekly

semi-solid

DRUGPlacebo Once Weekly

semi-solid

DRUGPlacebo Twice Weekly

semi-solid

Sponsors

Lumara Health, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Menstruating female 18-50 years of age, * Regular cycle length of 21 to 35 days with menstrual bleeding that typically lasts no more than 7 days, * Has pain associated with endometriosis, * Has a documented history consistent with endometriosis,

Exclusion criteria

* Is pregnant or lactating, * Has a history of or has active thrombosis

Design outcomes

Primary

MeasureTime frame
Pain associated with endometriosis3 months of treatment

Countries

Canada, Russia, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026